Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 22 Oct, 10:34 pm IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| CREDITACC CREDITACCESS GRAMEEN LIMITED Financial Services · Small | Sept 2026 22 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance raised | CreditAccess Grameen Limited reported strong financial and operating performance for Q2 FY27, driven by robust AUM growth, improving asset quality back to pre-crisis levels, and higher profitability resulting in the highest-ever quarterly PAT crossing INR 500 Cr. Management revised FY27 performance guidance upwards across key return and margin metrics, supported by disciplined operating costs and strong capital positions. Evidence summary ready | |
| AURUM Aurum PropTech Limited IT · Small | Sep 2026 22 Oct 2026 Preliminary brief | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | Aurum PropTech reported strong consolidated revenue growth of 57% YoY to Rs 137 Cr in Q2 FY27 along with an improvement in profitability margins, backed by aggressive AI transformation across platforms and upcoming integration of Housing.com. Evidence summary ready | |
| ROSSARI Rossari Biotech Limited Pharma · Small | Sep 2026 22 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | Rossari Biotech delivered its highest-ever quarterly revenue and EBITDA in Q2 FY27, supported by broad-based divisional growth and an improving export share. However, management remains cautious due to raw material volatility, Middle East geopolitical tensions impacting freight and logistics, and constrained ethylene oxide availability. Evidence summary ready | |
| FEDFINA Fedbank Financial Services Limited Financial Services · Micro | Sept 2026 22 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Fedbank Financial Services Limited delivered a strong Q2 FY27 with total disbursements up 28% YoY to INR6,676 crores and AUM up 37% YoY to INR22,035 crores. PAT reached INR130.8 crores (up 63% YoY), driven by an expanded ROA of 2.8% and ROE of 17%. Management highlighted that heightened competitive intensity in the gold loan market was managed effectively without compromising yields significantly, while mortgage collections and credit costs improved. Evidence summary ready | |
| IIFL IIFL Finance Limited Financial Services · Small | Sep 2026 22 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | IIFL Finance reported robust performance for Q2 FY27, with consolidated AUM reaching INR1,24,268 crores (up 38% YoY and 8% QoQ) and consolidated PAT crossing INR805 crores, up 13% QoQ and 93% YoY. The return on equity surpassed the 20% target at 20.1%, supported by steady asset quality (consolidated gross NPA improved by 7 bps QoQ to 1.48%), increased liquidity of INR13,805 crores, and stable capital adequacy of 23.5%. However, management faces challenges including capital-ra Evidence summary ready | |
| THELEELA Leela Palaces Hotels & Resorts Limited Consumer · Large | Sep 2026 22 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Leela Palaces Hotels & Resorts delivered exceptional performance in Q2 FY27 with 33% operating revenue growth and 36% EBITDA growth, supported by robust luxury demand, pricing power, and strong performance during marquee events like the BRICS summit in New Delhi. Evidence summary ready | |
| JINDALSAW Jindal Saw Limited Industrials · Large | Sept 2026 22 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Jindal Saw delivered higher year-on-year revenues for Q2 FY27 but faced severe operational margin compression due to geopolitical tensions in West Asia delaying shipments, higher international/domestic logistics costs, soaring coking coal prices, and softness in the domestic water infrastructure segment. Evidence summary ready | |
| IRFC Indian Railway Finance Corporation Limited Financial Services · Large | Sep 2026 22 Oct 2026 Transcript verified | Average 50/100 | Optimistic outlook No comparable prior call Guidance maintained | IRFC reported a robust performance for Q2 FY26-27, driven by successful business diversification and double-digit PAT growth across five of the last six quarters. Management remains confident in achieving its near-term and long-term AUM and profitability milestones while maintaining a low weighted average cost of capital. Evidence summary ready | |
| UJJIVANSFB Ujjivan Small Finance Bank Limited Financial Services · Micro | Sep 2026 22 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Ujjivan Small Finance Bank announced the early retirement of its MD & CEO due to health reasons and appointed Ms. Carol Furtado as Interim MD & CEO. Management reassured stakeholders of continuity in strategy, strong governance, and commitment to FY27 guidance, emphasizing that growth plans and capital adequacy remain unaffected by the leadership transition or potential delays in capital raising. The search for a permanent MD & CEO has been expedited. Evidence summary ready | |
| AYE Aye Finance Limited Financial Services · Small | Sept 2026 22 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Aye Finance Limited delivered a strong operational and financial performance in Q2 FY27, driven by robust AUM growth, improving asset quality, and record quarterly profitability supported by enhanced operational efficiency and lower credit costs. Evidence summary ready | |
| ELECON Elecon Engineering Company Limited Industrials · Large | Sept 2026 22 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call Guidance maintained | Elecon delivered resilient H1 FY27 performance with 11% consolidated revenue growth and a stable EBITDA margin of 22.2%, supported by robust international momentum in gears and recovering project clearances in the MHE division despite near-term domestic softness and raw material volatility. Evidence summary ready | |
| SRF SRF Limited Chemicals · Mid | Sept 2026 22 Oct 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call No measurable guidance | SRF Limited reported a consolidated revenue of 4,904.2 Cr and a PAT of 509.1 Cr for Q2 FY27, backed by robust growth in the Chemicals and Performance Films businesses, while navigating elevated input, freight, and fuel costs. Evidence summary ready | |
| JIOFIN Jio Financial Services Limited Financial Services · Large | Sep 2026 22 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Jio Financial Services reported strong operational scale-up across its core verticals during Q2 FY27, backed by 154% YoY growth in Jio Credit AUM and significant digital user engagement, though consolidated reported PAT declined due to shifting dividend timing effects compared to the previous year. Evidence summary ready | |
| LTM LTM Limited IT · Large | Sept 2026 22 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | LTM Limited reported steady Q2 FY2027 performance with 1.1% QoQ constant currency revenue growth and stable EBIT margins of 15.6%, while pivoting strongly toward AI-centric offerings and advancing strategic M&A execution. Evidence summary ready | |
| TARIL Transformers And Rectifiers (India) Limited Industrials · Large | Sept 2026 21 Oct 2026 Transcript verified | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Transformers and Rectifiers (India) Limited delivered robust performance in Q2 FY27 with revenue up 60.8% YoY and PAT jumping 120.0% YoY, supported by improved capacity utilization and operating leverage. Unexecuted order book remains strong at INR7,237 crore, providing solid multi-year visibility despite lingering working capital pressures and elevated inventory levels. Evidence summary ready | |
| IGIL International Gemmological Institute (India) Limited Services · Large | Sept 2026 21 Oct 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call No measurable guidance | International Gemmological Institute (India) Limited reported robust financial performance for Q2 FY27, with consolidated revenue up 31% YoY to INR 3,980 Mn and PAT up 43% YoY to INR 1,858 Mn, driven by strong growth in certification volumes and increased mix of lab-grown diamonds (LGD). Evidence summary ready | |
| 360ONE 360 ONE WAM LIMITED Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook No comparable prior call No measurable guidance | Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution. Evidence summary ready | |
| WAAREERTL Waaree Renewable Technologies Limited Industrials · Micro | Sept 2026 21 Oct 2026 Preliminary brief | Bad 2/100 | Optimistic outlook No comparable prior call No measurable guidance | Waaree Renewable Technologies Limited reported strong top-line growth with Q2 FY27 revenue up 36.5% YoY to Rs 1,057.84 Cr, alongside a healthy unexecuted order book exceeding Rs 5,500 Cr. However, PAT contracted by 29.98% YoY to Rs 81.48 Cr due to higher input costs, employee expenses, and financing costs, leading to margin compression. Evidence summary ready | |
| CCL CCL Products (India) Limited FMCG · Large | Sept 2026 21 Oct 2026 Transcript verified | Average 47/100 | Optimistic outlook No comparable prior call Guidance maintained | CCL delivered strong Q2 results with double‑digit volume growth and profit expansion, and management reaffirmed its FY27 guidance of ~15% volume and EBITDA growth, while noting coffee price volatility and capacity considerations. Evidence summary ready | |
| EMMVEE Emmvee Photovoltaic Power Limited Industrials · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 67/100 | Optimistic outlook No comparable prior call Guidance maintained | Emmvee delivered strong Q2 FY27 results with double‑digit revenue and profit growth, maintained high margins, and indicated that its expansion projects are on schedule, but future finance costs will rise post‑commissioning. Evidence summary ready | |
| SHOPERSTOP Shoppers Stop Limited Consumer · Small | Sep 2026 21 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance raised | Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation. Evidence summary ready | |
| DBCORP D.B.Corp Limited Media · Small | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | D.B. Corp reported a decline in Q2 FY27 revenue and PAT due to the festive season (Navaratra) shifting into Q3 and temporary headwinds such as panchayat election codes of conduct, though underlying advertising and EBITDA registered positive single-digit growth on a like-to-like basis. Evidence summary ready | |
| E2E E2E Networks Limited IT · Small | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance. Evidence summary ready | |
| ICICIPRULI ICICI Prudential Life Insurance Company Limited Financial Services · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 65/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms. Evidence summary ready | |
| SGFIN SG Finserve Limited Financial Services · Small | Sep 2026 21 Oct 2026 Transcript verified | Excellent 80/100 | Cautious outlook No comparable prior call New guidance | SG Finserve delivered strong Q2 FY27 results with record PAT and loan book growth, but management plans to increase leverage to 4x and targets 30‑35% AUM growth YoY, introducing execution and capital‑raising considerations. Evidence summary ready | |
| ANGELONE Angel One Limited Financial Services · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook No comparable prior call Guidance maintained | Angel One delivered resilient Q2 FY27 results with consolidated revenue of 14.3 billion rupees and PAT of 3.35 billion rupees despite subdued capital market volumes. Operating margins expanded significantly year-over-year, supported by operating leverage and a diversified revenue mix. Evidence summary ready | |
| HDFCAMC HDFC Asset Management Company Limited Financial Services · Large | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | HDFC Asset Management delivered solid revenue growth and maintained high profitability, while highlighting continued expansion of SIP inflows, alternative platform launches, and disciplined cost management; however, guidance on future revenue mix and margins remains limited. Evidence summary ready | |
| TIPSMUSIC Tips Music Limited Media · Micro | Sept 2026 21 Oct 2026 Transcript verified | Good 62/100 | Optimistic outlook No comparable prior call Guidance raised | Tips Music delivered strong top‑line and profit growth in Q2 FY27, driven by new releases and catalog performance across digital and non‑digital platforms. Management upgraded FY27 growth guidance but highlighted a front‑loaded content spend, ongoing YouTube Shorts negotiations and a smaller‑film focus for H2. Evidence summary ready | |
| HDBFS HDB Financial Services Limited Financial Services · Large | Sept 2026 20 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | HDB Financial Services delivered strong top‑line and profit growth in Q2 FY27, driven by robust disbursements across enterprise and consumer segments, improved asset quality and margins, and continued capital strength. Management is optimistic about H2, citing festive demand and capacity to scale, but flags monsoon‑related inflation, seasonal asset‑quality pressures and regulatory fee uncertainties as risks. Evidence summary ready | |
| PIRAMALFIN Piramal Finance Limited Financial Services · Small | Sep 2026 19 Oct 2026 Preliminary brief | Excellent 77/100 | Optimistic outlook No comparable prior call Guidance maintained | Piramal Finance Limited reported strong financial results for Q1 FY27, driven by robust growth in retail lending and a granular Wholesale 2.0 portfolio, while successfully continuing the rundown of legacy wholesale assets. The company maintains solid capitalization, high liquidity coverage, and a steadily improving operating leverage. Evidence summary ready | |
| IXIGO Le Travenues Technology Limited Consumer · Micro | Sep 2026 19 Oct 2026 Preliminary brief | Average 35/100 | Optimistic outlook No comparable prior call No measurable guidance | Le Travenues Technology Limited (IXIGO) reported resilient Q2 FY27 performance with GTV up 22% YoY and revenue from operations up 13% YoY to Rs 321 Crores, supported by strong growth in Flight and Bus segments and the new Hotel line. PAT reached an all-time high aided by a partial stake sale in Freshbus, while management continues to invest in hotels and AI capabilities. Evidence summary ready | |
| ULTRACEMCO UltraTech Cement Limited Materials · Large | Sept 2026 19 Oct 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call No measurable guidance | UltraTech Cement reported solid year-on-year volume and earnings growth for Q2 FY27 driven by strong structural macro demand, although fuel and raw material cost inflation impacted sequential margins. Evidence summary ready | |
| SEJALLTD Sejal Glass Limited Industrials · Small | Sep 2026 19 Oct 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Sejal Glass reported strong year-on-year revenue and profit growth for Q2 FY27, driven by higher capacity utilisation, integration of acquired Glasstech plants, and robust performance from its UAE subsidiary. Management remains optimistic about achieving 25% to 40% revenue growth in FY27, supported by scaling operations and new specialty product launches. Evidence summary ready | |
| UNIONBANK Union Bank of India Financial Services · Large | Sept 2026 19 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Union Bank of India delivered solid financial performance for Q2 FY2027 with strong growth in Net Interest Income, improved asset quality metrics including lower GNPA and NNPA ratios, and robust capital adequacy, alongside ongoing investments in digital initiatives and centralized surveillance systems. Evidence summary ready | |
| HERITGFOOD Heritage Foods Limited FMCG · Micro | Sept 2026 19 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook No comparable prior call No measurable guidance | Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially. Evidence summary ready | |
| POLYCAB Polycab India Limited Industrials · Mid | Sept 2026 19 Oct 2026 Transcript verified | Good 72/100 | Neutral outlook No comparable prior call Guidance maintained | Polycab delivered record revenue and profit growth in Q2 FY27, driven by strong demand across wires & cables and FMEG segments, while management reiterated an unchanged outlook despite macro‑headwinds and noted exposure to commodity and logistics risks. Evidence summary ready | |
| PSB Punjab & Sind Bank Financial Services · Small | Sept 2026 19 Oct 2026 Preliminary brief | Excellent 75/100 | Optimistic outlook No comparable prior call No measurable guidance | Punjab & Sind Bank reported steady financial growth for the quarter ended June 30, 2026, supported by an expanding RAM portfolio, improved asset quality metrics, and higher profitability ratios, although the source document is an investor presentation with earnings transcripts pending. Evidence summary ready | |
| YESBANK Yes Bank Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Yes Bank reported a Q2FY27 net profit of INR 1,080 crores, up 65% year-on-year, driven by healthy core operating income and steady asset quality, though the Supreme Court judgment on AT-1 bonds remains unrecognised pending assessment. Evidence summary ready | |
| TATAELXSI Tata Elxsi Limited IT · Mid | Sept 2026 19 Oct 2026 Transcript verified | Average 45/100 | Optimistic outlook No comparable prior call No measurable guidance | Tata Elxsi reported Q2 FY27 operating revenue of INR 1055.7 crores (up 2.3% QoQ in constant currency) and an EBITDA margin of 21.9%, absorbing annual wage hikes through operational leverage and realization of one-offs. While US and India markets performed well, Europe remains soft and sluggish, particularly in automotive. Management expects an upward margin trajectory and better second-half performance compared to the first half. Evidence summary ready | |
| ICICIGI ICICI Lombard General Insurance Company Limited Financial Services · Mid | Sept 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | ICICI Lombard General Insurance Company Limited reported robust H1 FY2027 performance, outpacing industry growth in segments like Retail Health and Commercial lines while maintaining strict underwriting discipline, though overall PBT and PAT dipped slightly and industry-wide Motor combined ratios remained heavily stressed. Evidence summary ready | |
| TATATECH Tata Technologies Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | Tata Technologies delivered solid revenue growth and maintained operating margin despite salary headwinds, but sequential PAT declined and technology solutions revenue fell due to accounting changes. Evidence summary ready | |
| KARURVYSYA Karur Vysya Bank Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript verified | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Karur Vysya Bank delivered strong revenue and profit growth in Q2 FY26-27, with business expansion and robust CASA inflows, while maintaining NIM above guidance; management signals cautious but optimistic outlook for FY26-27 growth of 18-20% and highlights competitive pressure on margins. Evidence summary ready | |
| IOLCP IOL Chemicals and Pharmaceuticals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | IOL Chemicals and Pharmaceuticals Limited reported its business update call focusing on three strategic growth initiatives totalling approximately INR500 crores, including Ibuprofen capacity expansion, entry into the CDMO formulations segment, and a specialty chemical tolling arrangement. Management highlighted disciplined internal accrual funding and long-term customer relationships, while noting that input prices have stabilized and some product prices have softened from pe Evidence summary ready | |
| TEMPSENS Tempsens Instruments (India) Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Tempsens Instruments (India) Limited reported a strong Q1 FY27 with revenue growing 33% YoY to INR118 crores and export revenues rising 78.3%, while EBITDA margins moderated by 330 bps to 22% due to employee cost investments for future growth and timing of execution. Evidence summary ready | |
| METROPOLIS Metropolis Healthcare Limited Pharma · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity. Evidence summary ready | |
| EUROPRATIK Euro Pratik Sales Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Euro Pratik Sales Limited announced the acquisition of a 56% stake in Fabwood Solutions LLP for up to INR42.7 crore to expand into timber and value-added wood products, while management guided for a 35% to 40% top-line growth rate for FY27. Evidence summary ready | |
| POLICYBZR PB Fintech Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | PB Fintech held an analyst and investor call addressing the draft regulatory proposals by the insurance regulator concerning commissions and distribution economics. Management stated that while life insurance NPV remains largely unaffected, general insurance (particularly retail health) faces a serious top-line compression of one-third to 40%. The company plans to absorb details, evaluate cost rationalization levers, and explore manufacturing and service monetization options. Evidence summary ready | |
| NOVARTIND Novartis India Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas. Evidence summary ready | |
| INDOBORAX Indo Borax & Chemicals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Indo Borax reported strong Q1 FY27 results with 31% operating revenue growth and a 59% jump in net profit, supported by robust execution and improved realizations. Management remains focused on operational efficiency, capacity utilization, and executing the acquisition of a majority stake in Kronox Lab Sciences. Evidence summary ready | |
| INDIGOPNTS Indigo Paints Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict. Evidence summary ready |